share_log

賽生藥業：建議重選董事及建議授出購回股份及發行股份之一般授權及建議採納第三份經修訂及重訂之組織章程細則及股東週年大會通告

SCICLONE PHARMA: PROPOSED RE-ELECTION OF DIRECTORS AND PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND PROPOSED ADOPTION OF THE THIRD AMENDED AND RESTATED ARTICLES OF ASSOCIATION AND NOTICE OF ANNUAL GENERAL MEETING

Hong Kong Stock Exchange ·  Apr 29 16:37
Summary by Futu AI
賽生藥業控股有限公司將於2024年6月28日在中國上海市舉行股東週年大會，會議將討論重選董事、授出購回股份及發行股份的一般授權，以及採納第三份經修訂及重訂的組織章程細則。股東若無法出席，需按代表委任表格指示填妥、簽署並於2024年6月26日前交回。此外，公司將於2024年6月25日至28日暫停股份過戶登記，以釐定出席大會及投票的股東資格。董事會已就重選董事、購回股份授權及發行股份授權的提案向股東提出建議，並認為這些提案符合公司及股東的最佳利益。
賽生藥業控股有限公司將於2024年6月28日在中國上海市舉行股東週年大會，會議將討論重選董事、授出購回股份及發行股份的一般授權，以及採納第三份經修訂及重訂的組織章程細則。股東若無法出席，需按代表委任表格指示填妥、簽署並於2024年6月26日前交回。此外，公司將於2024年6月25日至28日暫停股份過戶登記，以釐定出席大會及投票的股東資格。董事會已就重選董事、購回股份授權及發行股份授權的提案向股東提出建議，並認為這些提案符合公司及股東的最佳利益。
Saisheng Pharmaceutical Holdings Limited will hold its Annual General Meeting on 28 June 2024 in Shanghai, China. The meeting will discuss the re-election of directors, the granting of general mandates to repurchase and issue shares, and the adoption of a third revised and revised Articles of Association. If shareholders are unable to attend, they must complete, sign and return them by 26 June 2024 in accordance with the instructions of the Proxy Form. In addition, the Company will suspend the registration of shares from 25 to 28 June 2024 in order to determine the eligibility of shareholders to attend the general meeting and vote. The Board of Directors has made recommendations to shareholders regarding the proposals to re-elect directors, repurchase share warrants and issue share authorizations and considers these proposals to be in the best interests of the Company and shareholders.
Saisheng Pharmaceutical Holdings Limited will hold its Annual General Meeting on 28 June 2024 in Shanghai, China. The meeting will discuss the re-election of directors, the granting of general mandates to repurchase and issue shares, and the adoption of a third revised and revised Articles of Association. If shareholders are unable to attend, they must complete, sign and return them by 26 June 2024 in accordance with the instructions of the Proxy Form. In addition, the Company will suspend the registration of shares from 25 to 28 June 2024 in order to determine the eligibility of shareholders to attend the general meeting and vote. The Board of Directors has made recommendations to shareholders regarding the proposals to re-elect directors, repurchase share warrants and issue share authorizations and considers these proposals to be in the best interests of the Company and shareholders.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.